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Pfhrp-2 gene deletion is implicated in limiting RDT sensitivity.
Studies evaluating Pfhrp-2 and Pfhrp-3 deletion and the amino
acid sequence diversity has not been investigated in Nigeria.
We therefore hypothesised that malaria parasites in Nigeria
are lacking Pfhrp-2/Pfhrp-3 genes with variable amino acid
repeats sequences.
Methods The study was part of a prospective cohort study
evaluating RDTs performance. We pooled 66 samples compris-
ing false negatives (n=31) and true positives (n=35) to eluci-
date Pfhrp-2/Pfhrp-3 gene deletion, RDT cross-reactivity with
Pfhrp-3 antigen and amino acid sequence diversity. The
18SrRNA, msp 1, msp2 and glurp genes were amplified to
establish active Plasmodium falciparum infection and the
exon-2 regions of Pfhrp-2 and Pfhrp-3 genes were amplified
to determine the presence or absence of Pfhrp-2 and Pfhrp-3
genes. Isolates with conserved Pfhrp-2/Pfhrp-3 were
sequenced.
Results All 66 samples were positive for 18SrRNA, msp1,
msp2 and glurp, indicating active P. falciparum infection.
However, 16.7% and 6.0% of the samples were lacking
Pfhrp-2 and Pfhrp-3 genes. Of the false negative samples,
25.8% and 12.9% has Pfhrp-2 and Pfhrp-3 deletions. Three
Pfhrp-3 conserved antigens cross reacted to give RDT positive
results. An extensive diversity in the amino acid sequence was
observed.
Conclusion Plasmodium falciparum parasites in Nigeria lack
Pfhrp-2 and Pfhrp-3 genes. However, the proportion of dele-
tions is low compared to reports from other malaria-endemic
regions. In addition, a high amino acid tandem repeat was
observed. A combination of pLDH and Pfhrp-2 based RDTs is
recommended for accurate malaria diagnosis.
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Background The University of Cape Verde (Uni-CV) was
founded in 2006 and since then has developed an effective
international strategy that is enhancing the teaching and
research culture of the university. To build capacity in the
public health field, Uni-CV has established collaborations with
the University of Leicester (UoL), UK, and with the Institute
of Hygiene and Tropical Medicine (IHTM – NOVA Univer-
sity), Portugal. These follow different approaches.
Methods Different type of capacity building initiatives focused
on researchers and postgraduate students.
Results The collaboration with UoL was established in 2016
and builds on funded research programmes in infectious dis-
ease and evolution of antimicrobial drug resistance (AMR).
These programmes have allowed technology development and
transfer, which offer the opportunity for undergraduate stu-
dents to lead laboratory–based research projects at Uni-CV. In
these two years, we have successfully characterised the epi-
demiology and patterns of AMR underlying Helicobacter
pylori infections in Cape Verde. Beyond the research outputs,
we have trained four undergraduates in laboratory-based
microbiology at Uni-CV. From this experience, we are cur-
rently designing new sustainable higher education programmes
aligned with the MSc in Public health at Uni-CV that aim to
support Uni-CV lecturers in the supervision of postgraduate
students, either independently or in collaboration with UoL
researchers.
The collaboration with IHTM was established in 2008 with
the main aim of developing the research capacity of Cape
Verde researchers and health professionals in infection and
vector-born diseases and in bioethics. These activities have
also led to collaborative research in these areas. Since then,
six training courses were taught that benefited ~20 Uni-CV
lecturers and ~100 government professionals.
Conclusion Although these collaborative approaches are differ-
ent in nature, they have been successful in the training of
health professionals, researchers and technicians in Cape Verde
and have contributed to the establishment of mutually benefi-
cial research programmes.
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Background Plasmodium vivax malaria is a major health prob-
lem in Sudan and the parasite has become widely distributed
in the recent years. The WHO recommends the use of prima-
quine as radical cure for liver dormant stage, the hypnozoite.
However, prior its use, a test for Glucose-6-phosphate Dehy-
drogenase (G6PD) should be performed. The objective of the
current study was to determine prevalence and risk factors for
G6PD deficiency in two P. vivax malaria-endemic areas in
Sudan.
Methods A cross-sectional study recruiting 557 subjects from
two malaria-endemic areas in Sudan was conducted. Demo-
graphic data and blood samples were collected. G6PD activity
was measured by spectrometry using SPINREACT enzymatic-
UV kit.
Results The measured G6PD activities for both sites ranged
from 0.6 to 37.7 U/g Hb, with a median value of 12.8 U/g
Hb. There was a significant difference in enzyme activity by
study site (p<0.001), but not by sex (p=0.91). Overall, across
the two study sites, 22 (3.9%) is G6PDd (<30%). Prevalence
of G6PDd (<30%) in Khartoum is 1.8% (4/230) compared to
4.8% (16/327) in New Hafla. In univariate analysis predictors
of G6PDd were study site (odds ratio of G6PD activity <3.8,
Khartoum relative to New Halfa=0.22 (95% CI: 0.08 to
0.66), p=0.006), and recent antibiotic use (OR=2.45 (95%
CI: 1.1 to 5.5), p=0.027). In multivariate analysis, the only
factor that was significant was the individual’s weight in kilo-
grams, with an OR of 0.97 (95% CI 0.95 to 0.99, p=0.014).
Conclusion G6PD deficiency is less prevalent among Sudanese
population and this indicates that the use of primaquine for
radical cure of P. vivax malaria is safe.
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